Published May 30, 2019
Two institutions within the University at Buffalo have joined the National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic.
The joint commitment of the Jacobs School of Medicine and Biomedical Sciences and UB’s Clinical and Research Institute on Addictions (CRIA) makes UB one of more than 100 organizations to have joined the national effort.
In a statement issued April 30, the university’s leaders reaffirmed their commitment to combating the opioid crisis through collaborative, interdisciplinary efforts and partnerships.
The statement referred to UB’s more than 150 faculty members, working to advance research, education and clinical care on addiction, ranging from basic science to clinical and translational studies and health services research.
“Our clinical faculty see firsthand the damaged patients who present to our emergency rooms, clinics, private offices — and our morgues,” the statement said. “The Jacobs School of Medicine and Biomedical Sciences hosts one of the nation’s first fellowships in addiction medicine as well as a fellowship in pain medicine, training future clinical leaders and researchers in the field of addiction.”
Steps the CRIA’s researchers and clinicians have taken to address the epidemic are:
The CRIA is a research center of the University at Buffalo focused on addressing the causes, consequences, prevention and treatment of substance use disorders.
Its scientists are members of multiple departments and schools within UB, allowing CRIA to explore interdisciplinary methods to address addiction issues.
CRIA’s research programs are supported by federal, state and private foundation grants.